Seven Europe-based drug firms have announced plans to pool their research efforts together with universities and smaller companies in a project which aims to develop tomorrow’s medicines.
The European Lead Factory (ELF), backed by the EU, is backed by €196m ($265m). €80m ($107m) is being provided by the European Commission’s Seventh Framework Programme for Research (FP7), while a further €91m ($121m) will be provided by participating companies that are members of the European Federation of Pharmaceutical Industries and Associations…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?